Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment

Delafloxacin is a novel anionic fluoroquinolone with robust activity against Gram‐positive, Gram‐negative, atypical, and anaerobic bacteria, including methicillin‐resistant S aureus. Delafloxacin is currently being studied for the treatment of acute bacterial skin and skin structure infections and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoover, Randall, Marbury, Thomas C., Preston, Richard A., Quintas, Megan, Lawrence, Laura E., Paulson, Susan K., Luke, David R., Cammarata, Sue K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Special Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324641/
https://www.ncbi.nlm.nih.gov/pubmed/27570245
http://dx.doi.org/10.1002/jcph.817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324641/
https://www.ncbi.nlm.nih.gov/pubmed/27570245
http://dx.doi.org/10.1002/jcph.817

Ejemplares similares